{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:42:59Z","timestamp":1785894179304,"version":"3.56.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"sup3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1080\/1120009x.2004.11782371","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T06:32:44Z","timestamp":1477549964000},"page":"1-19","source":"Crossref","is-referenced-by-count":119,"title":["The Role of PK\/PD Parameters to Avoid Selection and Increase of Resistance: Mutant Prevention Concentration"],"prefix":"10.1080","volume":"16","author":[{"given":"J.M.","family":"Blondeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hedlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"CIT0007","unstructured":"Polk RE. Trends in fluoroquinolone (FG) prescribing in 35 US Hospitals and resistance forP. aeruginosa: a SCOPEMMIT report., Interscience Conference on Antimicrobial Agents and Chemotherapy, 2001. American Society of Microbiology, Washington, DC. Abstract UL-1."},{"key":"CIT0009","unstructured":"Iannini PB. Influence of fluoroquinolone usage of ciprofloxacin resistance ofPseudomonas aeruginosa. 3rdInternational Meeting on Antimicrobial Chemotherapy in Clinical Practice, Santa Margherita Ligure, October 16-19, 2003. Abstract #11."},{"key":"CIT0010","unstructured":"Mohr J, Jones A, Tillotson GS. Impact of antimicrobial usage on susceptibility ofPseudomonas aeruginosaover an eight-year period at a community-based teaching hospital. 3rdInternational Meeting on Antimicrobial Chemotherapy in Clinical Practice, Santa Margherita Ligure, October 16-19, 2003. Abstract #32."},{"key":"CIT0015","unstructured":"Dalhoff A, Heidtmann M, Obertegger S, Hesse D. Lack ofin vivoemergence of resistance against Bay 12-8039 inStaphylococcus aureusandStreptococcus pneumoniae. 8th International Conference on Infectious Diseases, Boston, MS, May 15-18, 1998. Abstract 124."},{"key":"CIT0016","unstructured":"Bhavnani SM, Hammel JP, Jones RN, Ambrose PG. Relationship between increased levofloxacin (LEV) use and decreased susceptibility ofStreptococcus pneumoniae(SP): report from the arrest program., 3rd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Santa Margherita Ligure, October 16-19, 2003. Abstract #35."},{"key":"CIT0017","unstructured":"Gootz TD, Brighty KE. Chemistry and mechanism of action of the quinolone antibacterials. In: Andriole VT, ed. The Quinolones. London, England: Academic Press Limited, 1998: 29-80."},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Kato H, Nishimura Y, Imamura R, Niki H, Hiraga S, Suzuki H. New topoisomerase essential for chromosome segregation inE.coli. Cell 1990; 63: 393-404.","DOI":"10.1016\/0092-8674(90)90172-B"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Gellert M, Muzuuchi K, O\u2019Dea MH, Itoh T, Tomizawa J. Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 1977; 74: 4772-4776.","DOI":"10.1073\/pnas.74.11.4772"},{"key":"CIT0051","unstructured":"National Committee for Clinical Laboratory Standards. Methods for ilution antimicrobial susceptibility tests for bacteria that grow erobically (M7-A6). National Committee for Clinical Laboratory Standards, 2003."},{"key":"CIT0058","unstructured":"Hansen G, Blondeau JM. Selection and characterization of fluoroquinolone resistantPseudomonas aeruginosaby ciprofloxacin (Cpx) and levofloxacin (Lfx) using high density cultures. 13th ECCMID, Glasgow, Scotland, May 10-13, 2003. Abstract."},{"key":"CIT0059","unstructured":"Metzler KL, Borsos S, Hansen G, Blondeau JM. Determination of the mutant prevention concentration (MPC) for several antimicrobial agents (AA) against clinical isolates ofStaphylococcus aureus(SA). Canadian Microbiology Association, Saskatoon, SK, Canada, June, 2002. Abstract."},{"key":"CIT0060","unstructured":"Hansen G, Metzler KL, Blondeau JM. Comparison of the minimum inhibitory concentration (MIC), mutant prevention concentration (MPC) and minimum bactericidal concentration (MBC) of ciprofloxacin (C) and levofloxacin (L) against enteric gram-negative bacilli (gnb). 41st International Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 19-22, 2002. American Society of Microbiology, Washington, DC."},{"key":"CIT0069","unstructured":"Blondeau JM, Metzler KL, Hansen G, Borsos S. Comparative mutant prevention concentration (MPC) and minimal inhibitory concentration (MIC) of gatifloxacin (GA), gemifloxacin (GM), levofloxacin (L) and moxifloxacin (MXF) against 101 isolates of methicillin-susceptibleStaphylococcus aureus(MSSA). 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 19-22, 2002. American Society of Microbiology, Washington, DC. Abstract."},{"key":"CIT0070","doi-asserted-by":"crossref","unstructured":"Metzler KL, Hansen G, Hedlin P, Harding E, Drlica K, Blondeau JM. Comparison of minimal inhibitory and mutant prevention concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and resistantStaphylococcus aureus. Int J Antimicrob Agents 2003; In Press.","DOI":"10.1016\/j.ijantimicag.2004.02.021"},{"key":"CIT0077","unstructured":"Hansen G, Zhao X, Drlica K, Blondeau JM. Mutant prevention concentration (MPC) of ciprofloxacin (C) and levofloxacin (L) against urinary isolates of Pseudomonas aeruginosa., 22nd International Congress of Chemotherapy, Amsterdam, 2001. International Society of Chemotherapy."},{"key":"CIT0078","unstructured":"Hansen G, Zhao X, Drlica K, Blondeau JM. Mutant prevention concentration (MPC) for quinolone and non-quinolone antimicrobial agents against clinical isolates ofPseudomonas aeruginosa(PA) and the effect of antibiotic combinations. 22nd International Congress of Chemotherapy, Amsterdam, The Netherlands, June 30-July 3, 2001. Abstract P27.109."},{"key":"CIT0079","unstructured":"Blondeau JM. Appropriate antibiotic use - past lessons provide future directions. International Congress and Symposium Series, Royal Society of Medicine Press Limited 2001:1-10."}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T23:02:34Z","timestamp":1568502154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1120009X.2004.11782371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":17,"journal-issue":{"issue":"sup3","published-online":{"date-parts":[[2016,10,27]]},"published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1080\/1120009X.2004.11782371"],"URL":"https:\/\/doi.org\/10.1080\/1120009x.2004.11782371","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}